Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

4.1K
4.1K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-Actuated Gene Editing in Human Kidney Organoids.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Co-induction of stromal and epithelial progenitors for renal regeneration.

Innovation (Cambridge (Mass.))·2026
Same author

Microenvironment optimization enables kidney organoid longevity with epithelial-endothelial joint basement membrane formation.

bioRxiv : the preprint server for biology·2026
Same author

Calcium Shock Enables Efficient and Programmable Particle Delivery for Genome Editing Applications.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration.

International journal of oral science·2026
Same author

Monitoring biological effects of somatic cell genome editing.

Nature reviews. Genetics·2026

Related Experiment Video

Updated: Apr 1, 2026

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells
09:05

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Published on: August 7, 2017

7.4K

iPS cell technology: Future impact on renal care.

Benjamin S Freedman, Theodore I Steinman

    Nephrology News & Issues
    |October 13, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Induced pluripotent stem (iPS) cells offer new avenues for kidney disease research and potential transplantation. Challenges remain in assessing cell maturity, function, and safety for clinical application in renal replacement therapy.

    More Related Videos

    Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
    07:22

    Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids

    Published on: September 1, 2023

    3.9K
    Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
    10:23

    Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

    Published on: November 4, 2022

    3.7K

    Related Experiment Videos

    Last Updated: Apr 1, 2026

    A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells
    09:05

    A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

    Published on: August 7, 2017

    7.4K
    Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
    07:22

    Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids

    Published on: September 1, 2023

    3.9K
    Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
    10:23

    Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

    Published on: November 4, 2022

    3.7K

    Area of Science:

    • Nephrology
    • Stem Cell Biology
    • Regenerative Medicine

    Background:

    • Induced pluripotent stem (iPS) cells derived from kidney disease patients represent a novel tool for advancing renal care.
    • These cells hold promise for modeling human kidney disease pathophysiology and developing immunocompatible, on-demand renal transplantation.

    Purpose of the Study:

    • To assess the potential of iPS cells in understanding kidney disease and developing new therapies.
    • To identify critical challenges and necessary advancements for clinical integration of iPS cell-based renal therapies.

    Main Methods:

    • Utilizing patient-derived iPS cells for in vitro modeling of kidney disease.
    • Evaluating the maturity and functional capacity of differentiated iPS cell types.
    • Assessing the potential for iPS cells in disease modeling, drug discovery, and preclinical testing.

    Main Results:

    • iPS cells provide a platform for studying human kidney disease mechanisms in a controlled laboratory setting.
    • Potential exists for iPS cells to contribute to drug discovery and testing for renal conditions.
    • Further research is needed to confirm safety and efficacy for clinical applications.

    Conclusions:

    • iPS cells are a promising tool for kidney disease research, offering insights into pathophysiology and potential therapeutic strategies.
    • Significant challenges related to cell maturity, function, safety, and clinical infrastructure must be overcome.
    • The ultimate goal is to develop improved, cost-effective renal replacement therapies and establish a new standard of care.